3.26.1 html 208 248 1 true 47 0 false 5 false false R1.htm 75000 - Document - Document and Entity Information Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 75010 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 75020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 75030 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss Condensed Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 75040 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 5 false false R6.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 6 false false R7.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 7 false false R8.htm 995455 - Disclosure - Organization and Summary of Significant Accounting Policies Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DisclosureOrganizationAndSummaryOfSignificantAccountingPolicies Organization and Summary of Significant Accounting Policies Notes 8 false false R9.htm 995465 - Disclosure - Collaboration and License Agreements Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreements Collaboration and License Agreements Notes 9 false false R10.htm 995475 - Disclosure - California Institute for Regenerative Medicine Award Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DisclosureCaliforniaInstituteForRegenerativeMedicineAward California Institute for Regenerative Medicine Award Notes 10 false false R11.htm 995485 - Disclosure - Investments Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DisclosureInvestments Investments Notes 11 false false R12.htm 995495 - Disclosure - Fair Value Measurements Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DisclosureFairValueMeasurements Fair Value Measurements Notes 12 false false R13.htm 995505 - Disclosure - Accrued Expenses Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DisclosureAccruedExpenses Accrued Expenses Notes 13 false false R14.htm 995515 - Disclosure - Leases Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DisclosureLeases Leases Notes 14 false false R15.htm 995525 - Disclosure - Convertible Preferred Stock and Stockholders' Equity Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DisclosureConvertiblePreferredStockAndStockholdersEquity Convertible Preferred Stock and Stockholders' Equity Notes 15 false false R16.htm 995535 - Disclosure - Segment Reporting Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/DisclosureSegmentReporting Segment Reporting Notes 16 false false R17.htm 995555 - Disclosure - Organization and Summary of Significant Accounting Policies (Policies) Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesPolicies Organization and Summary of Significant Accounting Policies (Policies) Policies http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DisclosureOrganizationAndSummaryOfSignificantAccountingPolicies 17 false false R18.htm 995565 - Disclosure - Organization and Summary of Significant Accounting Policies (Tables) Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesTables Organization and Summary of Significant Accounting Policies (Tables) Tables http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DisclosureOrganizationAndSummaryOfSignificantAccountingPolicies 18 false false R19.htm 995575 - Disclosure - Collaboration and License Agreements (Tables) Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsTables Collaboration and License Agreements (Tables) Tables http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreements 19 false false R20.htm 995585 - Disclosure - Investments (Tables) Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DisclosureInvestmentsTables Investments (Tables) Tables http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DisclosureInvestments 20 false false R21.htm 995595 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DisclosureFairValueMeasurements 21 false false R22.htm 995605 - Disclosure - Accrued Expenses (Tables) Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DisclosureAccruedExpensesTables Accrued Expenses (Tables) Tables http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DisclosureAccruedExpenses 22 false false R23.htm 995615 - Disclosure - Leases (Tables) Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DisclosureLeasesTables Leases (Tables) Tables http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DisclosureLeases 23 false false R24.htm 995625 - Disclosure - Convertible Preferred Stock and Stockholders' Equity (Tables) Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DisclosureConvertiblePreferredStockAndStockholdersEquityTables Convertible Preferred Stock and Stockholders' Equity (Tables) Tables http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DisclosureConvertiblePreferredStockAndStockholdersEquity 24 false false R25.htm 995635 - Disclosure - Segment Reporting (Tables) Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/DisclosureSegmentReportingTables Segment Reporting (Tables) Tables http://www.fatetherapeutics.com/20260630/taxonomy/role/DisclosureSegmentReporting 25 false false R26.htm 995645 - Disclosure - Organization and Summary of Significant Accounting Policies - (Additional Information) (Details) Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails Organization and Summary of Significant Accounting Policies - (Additional Information) (Details) Details http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesTables 26 false false R27.htm 995655 - Disclosure - Organization and Summary of Significant Accounting Policies - Schedule of reconciliation of cash, cash equivalents, and restricted cash (Details) Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesScheduleOfReconciliationOfCashCashEquivalentsAndRestrictedCashDetails Organization and Summary of Significant Accounting Policies - Schedule of reconciliation of cash, cash equivalents, and restricted cash (Details) Details 27 false false R28.htm 995665 - Disclosure - Organization and Summary of Significant Accounting Policies - Schedule of Basic and diluted net loss per share attributable to stockholders (Details) Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesScheduleOfBasicAndDilutedNetLossPerShareAttributableToStockholdersDetails Organization and Summary of Significant Accounting Policies - Schedule of Basic and diluted net loss per share attributable to stockholders (Details) Details 28 false false R29.htm 995675 - Disclosure - Organization and Summary of Significant Accounting Policies - Schedule of weighted-average outstanding shares of potentially dilutive Securities (Details) Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/DisclosureOrganizationAndSummaryOfSignificantAccountingPoliciesScheduleOfWeightedaverageOutstandingSharesOfPotentiallyDilutiveSecuritiesDetai Organization and Summary of Significant Accounting Policies - Schedule of weighted-average outstanding shares of potentially dilutive Securities (Details) Details 29 false false R30.htm 995685 - Disclosure - Collaboration and License Agreements (Details) Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsDetails3 Collaboration and License Agreements (Details) Details http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsTables 30 false false R31.htm 995695 - Disclosure - Collaboration and License Agreements (Details 1) Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsDetails1 Collaboration and License Agreements (Details 1) Details http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DisclosureCollaborationAndLicenseAgreementsTables 31 false false R32.htm 995715 - Disclosure - California Institute For Regenerative Medicine Award (Details) Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DisclosureCaliforniaInstituteForRegenerativeMedicineAwardDetails California Institute For Regenerative Medicine Award (Details) Details 32 false false R33.htm 995725 - Disclosure - Investments (Additional Information) (Details) Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails Investments (Additional Information) (Details) Details http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DisclosureInvestmentsTables 33 false false R34.htm 995735 - Disclosure - Investments (Details 1) Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/DisclosureInvestmentsDetails1 Investments (Details 1) Details http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DisclosureInvestmentsTables 34 false false R35.htm 995745 - Disclosure - Fair Value Measurements (Details) Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DisclosureFairValueMeasurementsDetails Fair Value Measurements (Details) Details http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DisclosureFairValueMeasurementsTables 35 false false R36.htm 995755 - Disclosure - Fair Value Measurements (Details 1) Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/DisclosureFairValueMeasurementsDetails1 Fair Value Measurements (Details 1) Details http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DisclosureFairValueMeasurementsTables 36 false false R37.htm 995765 - Disclosure - Accrued Expenses (Details) Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DisclosureAccruedExpensesDetails Accrued Expenses (Details) Details http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DisclosureAccruedExpensesTables 37 false false R38.htm 995775 - Disclosure - Leases (Additional Information) (Details) Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/DisclosureLeasesAdditionalInformationDetails Leases (Additional Information) (Details) Details http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DisclosureLeasesTables 38 false false R39.htm 995805 - Disclosure - Leases - Schedule of Future undiscounted minimum lease payments (Details) Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/DisclosureLeasesScheduleOfFutureUndiscountedMinimumLeasePaymentsDetails Leases - Schedule of Future undiscounted minimum lease payments (Details) Details 39 false false R40.htm 995825 - Disclosure - Convertible Preferred Stock and Stockholders' Equity (Additional information) (Details) Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersEquityAdditionalInformationDetails Convertible Preferred Stock and Stockholders' Equity (Additional information) (Details) Details http://www.fatetherapeutics.com/20260630/taxonomy/role/Role_DisclosureConvertiblePreferredStockAndStockholdersEquityTables 40 false false R41.htm 995835 - Disclosure - Convertible Preferred Stock and Stockholders' Equity - Stock option activity under all equity and stock option plans (Details) Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersEquityStockOptionActivityUnderAllEquityAndStockOptionPlansDetails Convertible Preferred Stock and Stockholders' Equity - Stock option activity under all equity and stock option plans (Details) Details 41 false false R42.htm 995845 - Disclosure - Convertible Preferred Stock and Stockholders' Equity - Restricted stock unit activity under all equity and stock option plans (Details) Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersEquityRestrictedStockUnitActivityUnderAllEquityAndStockOptionPlansDetails Convertible Preferred Stock and Stockholders' Equity - Restricted stock unit activity under all equity and stock option plans (Details) Details 42 false false R43.htm 995855 - Disclosure - Convertible Preferred Stock and Stockholders' Equity - Stock based compensation for all stock awards (Details) Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersEquityStockBasedCompensationForAllStockAwardsDetails Convertible Preferred Stock and Stockholders' Equity - Stock based compensation for all stock awards (Details) Details 43 false false R44.htm 995865 - Disclosure - Convertible Preferred Stock and Stockholders' Equity - Weighted average assumptions used in the Black-Scholes option pricing model (Details) Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersEquityWeightedAverageAssumptionsUsedInTheBlackscholesOptionPricingModelDetails Convertible Preferred Stock and Stockholders' Equity - Weighted average assumptions used in the Black-Scholes option pricing model (Details) Details 44 false false R45.htm 995875 - Disclosure - Convertible Preferred Stock and Stockholders' Equity - Reconciliation of Consolidated Stockholders' Equity Accounts (Details) Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/DisclosureConvertiblePreferredStockAndStockholdersEquityReconciliationOfConsolidatedStockholdersEquityAccountsDetails Convertible Preferred Stock and Stockholders' Equity - Reconciliation of Consolidated Stockholders' Equity Accounts (Details) Details 45 false false R46.htm 995885 - Disclosure - Segment Reporting (Additional Information) (Details) Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/DisclosureSegmentReportingAdditionalInformationDetails Segment Reporting (Additional Information) (Details) Details http://www.fatetherapeutics.com/20260630/taxonomy/role/DisclosureSegmentReportingTables 46 false false R47.htm 995895 - Disclosure - Segment Reporting - Schedule of Segment Profit or Loss, Including Segment Expenses (Details) Sheet http://www.fatetherapeutics.com/20260630/taxonomy/role/DisclosureSegmentReportingScheduleOfSegmentProfitOrLossIncludingSegmentExpensesDetails Segment Reporting - Schedule of Segment Profit or Loss, Including Segment Expenses (Details) Details 47 false false All Reports Book All Reports fate-20260630.htm fate-20260630.xsd http://fasb.org/us-gaap/2026 http://xbrl.sec.gov/dei/2026 http://xbrl.sec.gov/ecd/2026 false false